Tirzepatide (Mounjaro, Eli Lilly) is a long-acting dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide‑1 (GLP‑1) receptor agonist for subcutaneous injection with a ...

“Mounjaro is the brand name for tirzepatide, a weekly injectable weight-loss medication which has recently been approved for use in the UK and is now available to order with a prescription ...

Between January and May of this year there were 208 reports concerning tirzepatide on the Yellow Card scheme, which records ...

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.

Peptides, small chains of amino acids, have been hypothesized to play critical roles in various biological processes within organisms. Retatrutide and Tirzepatide have garnered significant ...